Primemd logo

Primemd(OTC) PRMD

Market Cap$1.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)-26%
5 Year+48%
1 Year+44,300%
1 Month+29,500%
$0.09
+0.00%
+0.00Today
Primemd last closing stock price
MetricPriceDate
Last closeUSD 0.092026-08-28
Primemd stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+26.86%USD 0.072026-08-12
1 month+29,500%USD 0.002026-07-10
3 month+7,972.73%USD 0.002026-04-20
Year to date+17,660%USD 0.002025-12-23
1 year+44,300%USD 0.002024-12-27
3 year+7,972.73%USD 0.002023-06-30
5 year+48%USD 0.062021-08-24
Since inception-26%USD 0.121990-10-24

Primemd Financials at a Glance

Market Cap

$1.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$10.50M

Net Income (TTM)

$3.14M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-16.98 (Low)

Price

$0.09

Volume

550

Open

$0.09

Previous Close

$0.09

Daily Range

$0.09 - $0.09

52-Week Range

$0.09 - $0.09

Estimated Earnings Date

May 10, 2024

PRMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Primemd

PrimeMD Inc. is a dynamic company engaged in the acquisition and development of residential and commercial real estate properties across the United States. Additionally, it holds interests in oil and gas properties, positioning itself as a multifaceted player in the healthcare and real estate sectors.

Products and Services
  • Development of residential and commercial real estate properties
  • Investment in oil and gas properties
  • Strategic partnerships for property management and development
Growth Outlook
  • Recent revenue of $1,643,110 indicates strong operational performance
  • Trailing twelve months (TTM) net income margin of 29.9% showcases profitability
  • Current ratio of 16.52 suggests robust liquidity and financial health
Financial Highlights
  • Quarterly revenue increased from $754,665 to $1,643,110 in Q3 2021
  • Net income of $2,628,110 reported in Q3 2021 reflects significant growth
  • Debt ratio of 46.55% indicates manageable leverage levels
PrimeMD Inc. has demonstrated a solid trajectory in revenue growth, particularly in the most recent quarter, where it reported a substantial increase in revenue compared to previous periods. The company's ability to maintain a high net income margin highlights its operational efficiency and profitability. With a current ratio significantly above 1, PrimeMD Inc. is well-positioned to meet its short-term obligations, indicating strong liquidity. The company's strategic focus on real estate and energy sectors provides a diversified revenue stream, which can be advantageous in varying market conditions. Overall, PrimeMD Inc. presents a compelling opportunity for investors interested in a company with a robust growth outlook and solid financial fundamentals.
AI Generated • Sep 16, 2026

Industry

Real Estate Management and Development

CEO

Raymond N. Joeckel

Headquarters

Littleton, CO 80123, US

PRMD Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

39.60%

Net Income Margin

29.90%

Return on Equity

73.34%

Return on Capital

28.74%

Return on Assets

20.49%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

18.70M

Volume

550

Avg. Volume

97.714

Financials (TTM)

Gross Profit

$10.50M

Operating Income

$4.10M

EBITDA

$4.03M

Operating Cash Flow

$3.02M

Capital Expenditure

-$772.47K

Free Cash Flow

$2.24M

Cash & ST Invst.

$2.59M

Total Debt

$7.13M

Primemd Performance Analysis

Primemd annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 10,501,684N/A
Primemd sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-03-31N/A
Q12021-06-30512.7%
Q22021-09-30-24.7%
Q32021-12-31-52.8%
Primemd annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.17N/A
Primemd sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-03-31N/A
Q12021-06-30-66.7%
Q22021-09-30-268.9%
Q32021-12-31796.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2021YOY CHG

Revenue

$1.64M

N/A

Gross Profit

$1.64M

N/A

Gross Margin

100.00%

N/A

Market Cap

$1.66MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.66M

N/A

Employees

1

N/A

Net Income

$2.63M

N/A

EBITDA

$3.40M

N/A

Quarterly Fundamentals

Name
Q3 2021YOY CHG

Total Cash

$2.59M

N/A

Total Debt

$7.13M

N/A

Accounts Receivable

$5.04M

N/A

Inventory

$0.00

N/A

Long Term Debt

$6.89M

N/A

Short Term Debt

$239.28K

N/A

Return on Assets

20.49%

N/A

Return on Invested Capital

27.98%

N/A

Free Cash Flow

$3.82M

N/A

Operating Cash Flow

$4.58M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BSSPBaseline Productions, Inc.
$0.00+0.00%
WIBFFWest Island Brands Inc.
$0.00+0.00%
AMBSAmarantus BioScience Holdings, Inc.
$0.00+0.00%
DECNDecision Diagnostics Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MEDSDataMEDS Ai
$6.07+274.69%
AALAmerican Airlines Group
$12.70-0.55%
NOKNokia
$10.14+3.05%
INTCIntel
$101.05+4.03%

Questions About PRMD

What is the current price of Primemd?

Primemd is trading at $0.09 per share.

What is the 52-week range for Primemd?

Over the past 52 weeks, Primemd has traded between $0.09 and $0.09.

How much debt does Primemd have?

As of the most recent reporting period, Primemd reported total debt of $7.13M.

How much cash does Primemd have on hand?

Primemd reported $2.59M in cash and cash equivalents in its most recent financial results.

What is Primemd’s dividend yield?

Primemd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.